What Does the Future of Cigarette Production Look Like in Australia as the Market Continues to Shrink?

Australia's tobacco landscape has transformed dramatically over the past two decades. Strict regulations, aggressive public health campaigns, and shifting consumer behaviours have driven cigarette consumption to historic lows. Official data from the Australian Institute of Health and Welfare shows daily smoking rates among adults fell from 24 per cent in 1995 to just 8.3 per cent in 2022, with projections indicating further declines. As production scales back in response to this shrinking market, questions arise about the industry's path forward. Will domestic manufacturing adapt, consolidate, or fade entirely? This post explores the trends shaping cigarette production in Australia, grounded in regulatory realities and market dynamics.

Regulatory Pressures Reshaping Production

Australia leads the world in tobacco control measures, creating a challenging environment for cigarette production. The Tobacco Plain Packaging Act of 2012 mandates drab, uniform packaging with graphic health warnings covering 75 percent of the front and back. This law, upheld by the High Court and WTO disputes, has made branded cigarettes visually indistinct, eroding marketing appeal.

Excise taxes add another layer of strain. As of 2025, these taxes exceed AUD 1 per cigarette, with annual indexation tied to Average Weekly Ordinary Time Earnings. The Australian Taxation Office reports tobacco excise revenue surpassing AUD 17 billion in 2023-24, funding health initiatives while pricing smokers out. Production facilities face rising costs for compliance, including annual licensing under the Tobacco Marketing Prohibition Act and stringent manufacturing standards enforced by the Therapeutic Goods Administration.

These rules have led to factory closures. British American Tobacco shut its Bellara plant in Queensland in 2019, citing unviable volumes. Philip Morris shifted much production offshore, importing from Southeast Asia. Local output now centres on a handful of sites, like Imperial Brands' facility in Laverton North, Victoria, but even these operate at reduced capacity. The result is a leaner, import-heavy supply chain, with domestic production volumes plummeting alongside consumption.

Declining Volumes and Economic Impacts

The market's contraction directly hits production. National Drug Strategy Household Survey data reveal a drop in smoking prevalence to under 10 per cent by 2022-23, with young adults leading the exodus. Vaping and nicotine pouches capture former smokers, while quitlines and programs like Quit for Life amplify cessation.

For manufacturers, this means underutilised plants and job losses. The Australian Bureau of Statistics notes that tobacco manufacturing employment has fallen by over 50 per cent since 2010. Factories that once ran multiple shifts now produce limited runs for the loyal base, estimated at 1.2 million daily smokers. Imports dominate, with 90 per cent of cigarettes sourced from abroad under strict border controls by the Australian Border Force.

This shift raises supply chain vulnerabilities. Global disruptions, like those during COVID-19, highlighted risks when overseas plants halted shipments. Producers must navigate biosecurity rules under the Biosecurity Act 2015, ensuring no contaminants enter. As volumes shrink further, economies of scale erode, pushing costs higher and profitability lower.

Innovation Amid Constraints: What Producers Are Doing

Faced with decline, remaining players innovate within tight bounds. Reduced ignition propensity cigarettes, mandated since 2010, minimise fire risks through specialised paper bands. These require precise manufacturing tweaks, but adoption has been slow due to costs.

Manufacturers also explore "next-generation" products, though regulated as tobacco. Heat-not-burn devices like IQOS face nicotine caps and flavour bans under the Public Health Tobacco Act 2002 amendments. Still, they represent a pivot from traditional combustibles. Domestic production trials these, blending local tobacco with imported components.

Sustainability enters the equation too. Water-efficient curing and waste reduction align with Australia's National Packaging Targets, aiming for 100 per cent reusable or recyclable packaging by 2025. Producers invest in biodegradable filters and reduced plastic in machinery, responding to environmental scrutiny from the Department of Climate Change, Energy, the Environment and Water.

Yet, innovation has limits. Advertising bans since 1992 and retail display prohibitions stifle promotion. Point-of-sale focus narrows to price and warnings, compressing margins. The future leans toward efficiency: automated lines for smaller batches, AI-driven quality control, and data analytics to forecast dwindling demand.

The Role of Imports and Offshore Shifts in Australia's Market

As local production wanes, imports fill the gap. Cigarettes Australia increasingly rely on certified overseas facilities vetted for Australian standards. This trend accelerates with free trade agreements like the Australia-UK deal, easing qualified imports while upholding health protocols.

Offshoring cuts costs but invites challenges. Currency fluctuations and shipping delays impact availability. The Australian Competition and Consumer Commission monitors for anti-competitive practices, ensuring fair pricing amid scarcity.

Projections from KPMG's global tobacco reports suggest Australia's market could halve by 2030, with production mirroring this. Surviving facilities might specialise in premium or duty-free lines for export, leveraging Australia's reputation for quality control.

Potential Pathways Forward

Looking ahead, cigarette production in Australia faces three plausible scenarios. First, further consolidation: a single major plant serving the domestic remnant, supplemented by imports. Second, full import reliance, with local sites repurposed for vaping or pharma-grade nicotine. Third, a gradual phase-out as prevalence dips below 5 per cent, aligning with World Health Organisation targets.

Public health experts, via Cancer Council Australia, advocate acceleration through higher taxes and broader bans. Industry counters with harm reduction arguments, citing evidence from New Zealand's smokefree push.

Government plays a pivotal role. The National Tobacco Strategy 2023-2030 prioritises supply reduction, potentially tightening import quotas. Meanwhile, economic modelling from Treasury warns of lost revenue, balanced against healthcare savings estimated at AUD 2.5 billion annually.

Navigating the Shift: Practical Considerations for Stakeholders

For retailers and consumers, adaptation means stocking compliant stock and monitoring price hikes. Producers focus on compliance tech, like blockchain for traceability, under proposed digital regulations.

Ultimately, the future tilts toward contraction. Production will persist at minimal levels, sustained by a shrinking cohort and robust imports.

For reliable access to quality options amid these changes, turn to trusted suppliers like My Cigs Australia. They specialise in compliant, Australia-focused solutions, helping navigate the evolving landscape with expertise and reliability.